2005
DOI: 10.1200/jco.2005.23.16_suppl.3210
|View full text |Cite
|
Sign up to set email alerts
|

Effects of imatinib on breast cancer cell biology in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…For example, imatinib has been shown to have anti-proliferative, cytostatic and apoptotic effect due to its ability to block the platelet derived growth factor receptor (PDGF-Rβ). [53][54][55][56][57] Additionally, tamoxifen has been shown to induce apoptosis mediated by an oestrogen-independent pathway in triple negative breast cancer cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-453 and SK-BR-3). 58,59 Doxorubicin is a DNA alkylator which is used in the treatment of triple negative breast cancer and its activity against MDA MB 231 is well documented.…”
Section: Resultsmentioning
confidence: 99%
“…For example, imatinib has been shown to have anti-proliferative, cytostatic and apoptotic effect due to its ability to block the platelet derived growth factor receptor (PDGF-Rβ). [53][54][55][56][57] Additionally, tamoxifen has been shown to induce apoptosis mediated by an oestrogen-independent pathway in triple negative breast cancer cell lines (MDA-MB-231, MDA-MB-468, MDA-MB-453 and SK-BR-3). 58,59 Doxorubicin is a DNA alkylator which is used in the treatment of triple negative breast cancer and its activity against MDA MB 231 is well documented.…”
Section: Resultsmentioning
confidence: 99%